What is Stevanato Group?
Stevanato Group stands as a global leader in the provision of integrated containment and delivery systems for the biopharmaceutical and diagnostic sectors. By leveraging proprietary glass-forming technology and a comprehensive suite of services—ranging from plastic components for medical devices to advanced inspection and packaging machinery—the company maintains a critical role in the drug delivery ecosystem. Its market position is defined by a commitment to high-standard quality control and a multi-disciplinary approach that serves both established pharmaceutical giants and emerging biotech innovators. The firm's ability to integrate manufacturing services with precision engineering ensures it remains a preferred partner for complex drug delivery requirements.
How much funding has Stevanato Group raised?
Stevanato Group has raised a total of $1B across 3 funding rounds:
Share Placement
$672M
Debt
$137M
Debt
$235.4M
Share Placement (2021): $672M, investors not publicly disclosed
Debt (2023): $137M led by CDP Venture Capital SGR and BNP Paribas
Debt (2025): $235.4M supported by BNP Paribas, Cdp, and BANCO BPM
Key Investors in Stevanato Group
BNP Paribas
A leading international banking group headquartered in Paris, providing comprehensive corporate and institutional banking services, including debt capital markets and structured finance.
Cdp
The national promotional institution of Italy, dedicated to financing public investments and acting as a catalyst for national infrastructure and industrial growth.
CDP Venture Capital SGR
A prominent European venture capital manager focusing on strategic investments in high-growth sectors such as digital health, fintech, and industrial innovation.
What's next for Stevanato Group?
Looking ahead, the recent infusion of capital is expected to accelerate Stevanato Group's strategic initiatives, particularly in the expansion of its contract manufacturing capabilities and the enhancement of its automated inspection technologies. As the biopharmaceutical industry faces increasing pressure for high-quality, scalable delivery solutions, the company is well-positioned to leverage its recent financing to optimize production capacity and deepen its footprint in key international markets. By focusing on innovation-led growth and operational excellence, Stevanato Group aims to maintain its competitive edge, ensuring that its infrastructure remains aligned with the evolving needs of global healthcare providers and diagnostic laboratories.
See full Stevanato Group company page
